Section Arrow
YDES.NASDAQ
- YD Bio Limited
Quotes are at least 15-min delayed:2026/02/20 01:34 EST
Regular Hours
Last
 8.8
+0.278 (+3.26%)
Day High 
8.952 
Prev. Close
8.522 
1-M High
12.5 
Volume 
23.13K 
Bid
8.77
Ask
8.95
Day Low
8.4 
Open
8.56 
1-M Low
8.405 
Market Cap 
600.98M 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 10.36 
20-SMA 11.1 
50-SMA 11.82 
52-W High 31 
52-W Low 5.3 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-0.02/--
Enterprise Value
600.99M
Balance Sheet
Book Value Per Share
0.07
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
0
Operating Revenue Per Share
--
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
TOVXTheriva Biologics Inc0.1967+0.0047+2.45%0.09PE
IBRXImmunityBio8.61+0.07+0.82%-- 
DRMADermata Therapeutics Inc1.93+0.65+50.78%0.08PE
QNCXQuince Therapeutics0.1622-0.0158-8.88%-- 
LIMNLiminatus Pharma Inc0.2383-0.0066-2.69%-- 
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
YD Bio Ltd is a biopharmaceutical company focusing on blood-based cancer detection, the development of stem cell- and exosome-based therapeutics with the potential to transform the treatment of a wide spectrum of diseases with high unmet medical need and serving as a trusted supplier of clinical testing drugs for pharmaceutical companies. Stem cell therapy uses versatile cells to repair or regenerate damaged tissues, offering innovative treatments for injuries, degenerative diseases, and immune disorders with potential for personalized medicine and tissue engineering.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.